Manversation

The Campaign For Prostate Cancer Conversations

The Manversation campaign has been developed in consultation with leading prostate cancer charities
Orchid Male Cancer and Tackle Prostate Cancer. The campaign has been organised and funded by Bayer.

Manversation

Manversation is a new disease awareness campaign that aims to raise awareness of the symptoms of advanced prostate cancer. The Manversation campaign has been developed in consultation with leading prostate cancer charities Orchid Male Cancer and Tackle Prostate Cancer. The campaign has been organised and funded by Bayer.

Manversation aims to:

  • Raise awareness of the symptoms of advanced prostate cancer
  • Challenge the outdated stereotype that men avoid addressing their health concerns
  • encourage men to speak up about potential symptoms as soon as they develop

Our Survey

The need for our campaign was highlighted by a national survey* of over 3,000 people in the UK that challenged the now outdated view that men are reluctant to discuss their health concerns with family and healthcare professionals.

However, the survey also highlighted a lack of awareness of symptoms indicative of worsening or progressing prostate cancer, which worryingly was similar amongst men with direct or indirect experience of the disease and those who had no connection to the disease.1 This may be preventing men with prostate cancer seeking the help they need.

Men are talking about health

  • 82% of men who have access to a doctor have discussed a symptom that was worrying them, with a doctor1
  • Over a quarter of men (28%) who have access to a doctor regularly visited their doctor, having consulted their doctor about a worrying symptom at least every 6 months1
  • However, almost 1 in 6 men were unable to identify a single symptom that could reveal a potentially advanced form of the disease1

What’s the picture where you live?

Select a region to reveal how men responded to the survey at a local level.1

London
Question Response
Have discussed a worrying symptom
with their doctor
81%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
24%
Unable to identify a symptom related
to advanced prostate cancer
21%
Scotland
Question Response
Have discussed a worrying symptom
with their doctor
89%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
23%
Unable to identify a symptom related
to advanced prostate cancer
15%
Glasgow
Question Response
Have discussed a worrying symptom
with their doctor
95%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
23%
Unable to identify a symptom related
to advanced prostate cancer
17%
Newcastle
Question Response
Have discussed a worrying symptom
with their doctor
76%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
26%
Unable to identify a symptom related
to advanced prostate cancer
14%
Birmingham
Question Response
Have discussed a worrying symptom
with their doctor
78%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
25%
Unable to identify a symptom related
to advanced prostate cancer
22%
Southampton
Question Response
Have discussed a worrying symptom
with their doctor
80%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
34%
Unable to identify a symptom related
to advanced prostate cancer
15%
Liverpool
Question Response
Have discussed a worrying symptom
with their doctor
78%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
23%
Unable to identify a symptom related
to advanced prostate cancer
15%
Leeds
Question Response
Have discussed a worrying symptom
with their doctor
93%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
22%
Unable to identify a symptom related
to advanced prostate cancer
15%
Midlands
Question Response
Have discussed a worrying symptom
with their doctor
82%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
31%
Unable to identify a symptom related
to advanced prostate cancer
17%
North East
Question Response
Have discussed a worrying symptom
with their doctor
79%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
33%
Unable to identify a symptom related
to advanced prostate cancer
13%
North West
Question Response
Have discussed a worrying symptom
with their doctor
86%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
20%
Unable to identify a symptom related
to advanced prostate cancer
13%
Question Response
Have discussed a worrying symptom
with their doctor
%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
%
Unable to identify a symptom related
to advanced prostate cancer
%
South East
Question Response
Have discussed a worrying symptom
with their doctor
77%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
33%
Unable to identify a symptom related
to advanced prostate cancer
13%
South West
Question Response
Have discussed a worrying symptom
with their doctor
77%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
32%
Unable to identify a symptom related
to advanced prostate cancer
17%
Wales
Question Response
Have discussed a worrying symptom
with their doctor
90%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
35%
Unable to identify a symptom related
to advanced prostate cancer
9%
Yorkshire
Question Response
Have discussed a worrying symptom
with their doctor
91%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
41%
Unable to identify a symptom related
to advanced prostate cancer
15%
Edinburgh
Question Response
Have discussed a worrying symptom
with their doctor
83%
Visit their doctor at least every
6 months to discuss a symptom
that was worrying them
24%
Unable to identify a symptom related
to advanced prostate cancer
12%

*Survey findings relating to men are specific to men aged 40 years or over
who have access to a doctor

  • 1. Censuswide. 2016. Prostate cancer disease awareness campaign (3,038 sample). Survey organised and funded by Bayer plc